Novo Nordisk Partners With OpenAI to Embed AI Agents Across Drug Discovery and Global Operations
The Danish pharmaceutical giant will integrate OpenAI's frontier models across R&D, manufacturing, and supply chain, with full deployment targeted by year-end.